• Ulcemesa- Mesalamine 1200 mg Prolonged-Release Tablets Suppliers, Wholesalers, Distributors, Pcd pharma franchise 1

Ulcemesa- Mesalamine 1200 mg Prolonged-Release Tablets Suppliers, Wholesalers, Distributors, Pcd pharma franchise

PCD Pharma Franchise Companies Delhi
Demax biotech Is delhi based Pharma Ethical marketing company. Now we have launch our new products Ulcemesa- Mesalamine 1200 mg Prolonged-Release Tablets. Reliable Anti-Inflammatory that act throughout both the small & large intestine, Ulcemesa- Mesalamine 1200 mg Prolonged-Release Tablets,Proven Efficacy for Inflamed Bowel. Ulcemesa is the first-line treatment for patients with mild-to moderate UC (ulcerative colitis). Ulcemesa is not effective in achieving remission but also in maintaining remission in patients with recurrent symptomatic diverticular disease. We are offering pharma pcd franchise monopoly rights for Gastro range. We are operating in Delhi as ethical marketing Company, Now We want to expand our working area.
Contact Supplier

Demax Biotech Pvt Ltd.

WZ-7&8 GROUND FLOOR, LAWRENCE ROAD,, PHOOL BAGH RAMPURA, Delhi New Delhi 110035
     
About Company

Nature of Business

Pharma Franchise Company & Pharma PCD Company

Number of Employees

11 to 25 People

Annual Turnover

Rs. 10 - 25 Crore

Member Since Rednirus Mart

Aug 2022

Demax Biotech Pvt. Ltd. – About Us

Demax Biotech Pvt. Ltd is a pharmaceutical firm with its major focus on offering quality protein powders, health supplements and more at reasonable costs to all. Committed to making life safer, Demax Biotech is an ISO certified company, backed by an extensive experience, coupled with sophisticated Pharma professionals and skilled team who established the Demax Biotech as a trusted name in the Pharmaceutical industry globally.

We are fast growing Indian Pharmaceuticals Company engaged in developing and marketing wide range of pharmaceuticals worldwide. We believe that our competitive benefit in domestic market lies in our recognized presence in all main therapeutic areas consisting of:

  • Diabetes Care

  • Cardiology

  • Anti-Inflammatory

  • Nephrology

  • Skin Care

  • Vitamin & Nutria Products

  • Gynecological

We develop an extensive portfolio of pioneering pharmaceutical products addressing several needs of patients suffering from different ailments by developing better-quality products where conventional formulations have limited efficacy and to reformulate pharmaceutical compounds with known safety and effectiveness.

The company belongs to an entity of various companies that are limited by shares and have an authorized capital of rupee 1,000,000 and paid up capital of 500,000 rupee. The registration number for the company is 269684. We are registered under the Non-Governmental category of companies. The type of the company is Unlisted Public Company with two owners: Pawan Kumar Mittal and Gaurav Mittal. The effort of the company is to present all the information regarding the company in the database which is provided by them.

We, at Demax Biotech value the relationship with our valued clients and believe in 'Customer Centric' approach and measure our performance on the value delivered to our clients collectively. We aim at providing timely and genuine solutions keeping commitments in true spirits. Prompt responsiveness and acceptance of Audit compliance is a natural corollary. To its unsurpassed quality and unparalleled service, the company has got all that it takes to sustain its commitment to excellence.

Send Enquiry